Relievant Medsystems Announces Publication of ASPN Guidelines on the Diagnosis and Treatment of Vertebrogenic Low Back Pain with Basivertebral Nerve Ablation
“With strong clinical evidence including two level I randomized controlled trials and long-term data supporting the efficacy and safety of BVN ablation, this treatment option has taken an increasingly important role in the approach to treating chronic vertebrogenic low back pain in recent years,” said Professor Dawood Sayed M.D